Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

Combination pharmacotherapy has simplified and improved glaucoma medication regimens. This update focuses on the previous and recent studies on efficacy and tolerability profile of dorzolamide–timolol in adult ocular hypertension and open angle glaucoma patients. Dorzolamide–timolol has been shown t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichhpujani, Parul, Katz, L Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108696/
https://www.ncbi.nlm.nih.gov/pubmed/21701619
_version_ 1782205354841473024
author Ichhpujani, Parul
Katz, L Jay
author_facet Ichhpujani, Parul
Katz, L Jay
author_sort Ichhpujani, Parul
collection PubMed
description Combination pharmacotherapy has simplified and improved glaucoma medication regimens. This update focuses on the previous and recent studies on efficacy and tolerability profile of dorzolamide–timolol in adult ocular hypertension and open angle glaucoma patients. Dorzolamide–timolol has been shown to be efficacious and well tolerated in clinical trials and the adverse effects reflect those of the individual components.
format Online
Article
Text
id pubmed-3108696
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-31086962011-06-23 Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension Ichhpujani, Parul Katz, L Jay Drug Healthc Patient Saf Review Combination pharmacotherapy has simplified and improved glaucoma medication regimens. This update focuses on the previous and recent studies on efficacy and tolerability profile of dorzolamide–timolol in adult ocular hypertension and open angle glaucoma patients. Dorzolamide–timolol has been shown to be efficacious and well tolerated in clinical trials and the adverse effects reflect those of the individual components. Dove Medical Press 2010-05-24 /pmc/articles/PMC3108696/ /pubmed/21701619 Text en © 2010 Ichhpujani and Katz, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Ichhpujani, Parul
Katz, L Jay
Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title_full Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title_fullStr Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title_full_unstemmed Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title_short Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
title_sort efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108696/
https://www.ncbi.nlm.nih.gov/pubmed/21701619
work_keys_str_mv AT ichhpujaniparul efficacysafetyandtolerabilityofcombinationtherapywithtimololanddorzolamideinglaucomaandocularhypertension
AT katzljay efficacysafetyandtolerabilityofcombinationtherapywithtimololanddorzolamideinglaucomaandocularhypertension

Ejemplares similares